Gefitinib in Combination with Irradiation with or Without Cisplatin in Patients with Inoperable Stage III Non-Small Cell Lung Cancer: A Phase I Trial

Rothschild, Sacha; Bucher, Stephan E; Bernier, Jacques; Aebersold, Daniel M; Zouhair, Aberrahim; Ries, Gerhard; Lombrieser, Norbert; Lippuner, Thomas; Lütolf, Urs M; Glanzmann, Christoph; Ciernik, I Frank (2011). Gefitinib in Combination with Irradiation with or Without Cisplatin in Patients with Inoperable Stage III Non-Small Cell Lung Cancer: A Phase I Trial. International journal of radiation oncology, biology, physics, 80(1), pp. 126-32. New York, N.Y.: Elsevier 10.1016/j.ijrobp.2010.01.048

Full text not available from this repository. (Request a copy)

To establish the feasibility and tolerability of gefitinib (ZD1839, Iressa) with radiation (RT) or concurrent chemoradiation (CRT) with cisplatin (CDDP) in patients with advanced non-small cell lung cancer (NSCLC).

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Radiation Oncology

UniBE Contributor:

Aebersold, Daniel

ISSN:

0360-3016

Publisher:

Elsevier

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:08

Last Modified:

17 Mar 2015 19:08

Publisher DOI:

10.1016/j.ijrobp.2010.01.048

PubMed ID:

20646869

Web of Science ID:

000290006300019

URI:

https://boris.unibe.ch/id/eprint/398 (FactScience: 198394)

Actions (login required)

Edit item Edit item
Provide Feedback